Leukemia Research
Volume 30, Issue 4 , Pages 389-395, April 2006

Minimal residual core binding factor AMLs by real time quantitative PCR—Initial response to chemotherapy predicts event free survival and close monitoring of peripheral blood unravels the kinetics of relapse

  • Jesper Stentoft

      Affiliations

    • Department of Hematology, Aarhus University Hospital, Tage-Hansens Gade 2, DK-8000 Aarhus C, Denmark
    • Corresponding Author InformationCorresponding author. Tel.: +45 89497926; fax: +45 89497589/99.
    • ,
  • Peter Hokland

      Affiliations

    • Department of Hematology, Aarhus University Hospital, Tage-Hansens Gade 2, DK-8000 Aarhus C, Denmark
    • ,
  • Mette Østergaard

      Affiliations

    • Department of Hematology, Aarhus University Hospital, Tage-Hansens Gade 2, DK-8000 Aarhus C, Denmark
    • ,
  • Henrik Hasle

      Affiliations

    • Department of Pediatrics, Aarhus University Hospital, Denmark
    • ,
  • Charlotte Guldborg Nyvold

      Affiliations

    • Department of Hematology, Aarhus University Hospital, Tage-Hansens Gade 2, DK-8000 Aarhus C, Denmark

Received 14 April 2005; received in revised form 24 August 2005; accepted 24 August 2005. published online 07 March 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(05)00333-4

doi:10.1016/j.leukres.2005.08.030

Leukemia Research
Volume 30, Issue 4 , Pages 389-395, April 2006

Article Tools

* Image Usage & Resolution